Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01
FDA recall notice · announced November 4, 2015 · Pfizer
Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.
The product
Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01
Reason for recall
Subpotent Drug
Notes
Distribution: Nationwide
Lot/code information: Lot # C111054; Exp. 02/16
Quantity: 21,120 HDPE bottles
Status: Terminated
Products in this recall event:
- Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01 (D-0161-2016)
Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.